Morris Nichols Bankruptcy Alert - Novum Pharma, LLC Files Chapter 11 Bankruptcy Case in Delaware

On February 3, 2019, Novum Pharma, LLC filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. As a courtesy to our clients and friends, the Morris Nichols Business Reorganization & Restructuring Group has summarized information related to the filing below.

Lead Case No. – 19-10209.

Debtor – Novum Pharma, LLC.

Description of Debtor – Specialty pharmaceutical company.

Website of Debtor's (URL)

Assigned Judge – The Honorable Kevin J. Carey.

Proposed Counsel – The Debtor's proposed bankruptcy counsel is Cole Schotz P.C. 

Proposed Financial Advisor – CR3 Partners, LLC.

Proposed Investment Banker – Teneo Capital LLC.

Proposed CRO – Thomas S. O'Donoghue, Jr.

Plan Status – No plan was filed with the petition. 

First Day Hearing – A first day hearing has been scheduled for February 5, 2019 at 2:30 p.m. ET. 

Bankruptcy Documents  –

Please do not hesitate to contact any member of the Morris Nichols Business Reorganization & Restructuring Group if we can be of assistance.


Delaware's Leading
Legal Practice Publications

fully text searchable, quick-find sections, bookmarkable pages